GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Total Current Assets

AngioDynamics (FRA:UG2) Total Current Assets : €156.5 Mil (As of Aug. 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. AngioDynamics's total current assets for the quarter that ended in Aug. 2024 was €156.5 Mil.


AngioDynamics Total Current Assets Historical Data

The historical data trend for AngioDynamics's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Total Current Assets Chart

AngioDynamics Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.22 115.94 135.60 150.46 178.76

AngioDynamics Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.91 171.37 182.53 178.76 156.54

AngioDynamics Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

AngioDynamics's Total Current Assets for the fiscal year that ended in May. 2024 is calculated as

AngioDynamics's Total Current Assets for the quarter that ended in Aug. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


AngioDynamics  (FRA:UG2) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

AngioDynamics's Liquidation Value for the quarter that ended in Aug. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=49.89-88.021+0.75 * 35.884+0.5 * 58.683
=18.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioDynamics Total Current Assets Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

AngioDynamics Headlines

No Headlines